What is Pancragen?
Pancragen is a synthetic tetrapeptide with the sequence Lys-Glu-Asp-Trp (KEDW). It is one of the short “peptide bioregulators” studied by Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology. In that group’s published work it is associated with the pancreas and has been examined in human pancreatic cell cultures.
Pancragen product specifications
- Compound: Pancragen
- Sequence: Lys-Glu-Asp-Trp (KEDW, 4 amino acids)
- Molecular formula: C26H36N6O9
- Molecular weight: about 576.6 g/mol
- Vial size: 20mg
Regulatory status
Pancragen is not an approved medicine in the US, UK, EU or Canada. Most published research on it comes from a single research group, so independent confirmation is limited. This product is sold for laboratory research use only.
Related bioregulator peptides
- Livagen (KEDA), Prostamax (KEDP) and Testagen (KEDG) share its Lys-Glu-Asp start.
- Epithalon is the best-known peptide of this research line.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
